Pediatric status epilepticus: improved management with new drug therapies?

References

• Abend NS, Loddenkemper T. Pediatric status epilepticus management. Curr Opin Pediatr. 2014;26:668–674.
   PubMed Web of Science ®Google Scholar
• Trinka E, Cock H, Hesdorffer D, et al. A definition and classification of status epilepticus-report of the ILAE task force on classification of status epilepticus. Epilepsia. 2015;56:1515–1523.
   PubMed Web of Science ®Google Scholar
• Capovilla G, Beccaria F, Beghi E, et al. Treatment of convulsive status epilepticus in childhood: recommendations of ILAE. Epilepsia. 2013;54:23–34.
   PubMed Web of Science ®Google Scholar
• Trinka E, Höfler J, Leitinger M, et al. Pharmacotherapy for status epilepticus. Drugs. 2015;75:1499–1521.
   PubMed Web of Science ®Google Scholar
• Smith D, McGinnis E, Walleigh D, et al. Management of status epilepticus in children. J Clin Med. 2016;13:5.
   Google Scholar
• Neubauer BA, Hahn A. Syndromes at risk of status epilepticus in children: genetic and pathophysiological issues. Epileptic Disord. 2014;16:S89–95.
   PubMed Web of Science ®Google Scholar
• Le Gal F, Lebon S, Ramelli GP, et al. When is a child with status epilepticus likely to have dravet syndrome? Epilepsy Res. 2014;108:740–747.
   PubMed Web of Science ®Google Scholar
• Myers KA, McMahon JM, Mandelstam SA, et al. Fatal cerebral edema with status epilepticus in children with dravet syndrome: report of 5 cases. Pediatrics. 2017;22:e20161933.
   Web of Science ®Google Scholar
• Van Baalen A, Häusler M, Boor R, et al. Febrile infection-related epilepsy syndrome (FIRES): a nonencephalitic encephalopathy in childhood. Epilepsia. 2010;51:1323–1328.
   PubMed Web of Science ®Google Scholar
• Nabbout R, Vezzani A, Dulac O, et al. Acute encephalopathy with inflammation-mediated status epilepticus. Lancet Neurol. 2011;10:99–108.
   PubMed Web of Science ®Google Scholar
• Panayiotopoulos CP, Michael M, Sanders S, et al. M.Benign childhood focal epilepsies: assessment of established and newly recognized syndromes. Brain. 2008;131:2264–2286.
   PubMed Web of Science ®Google Scholar
• Capovilla G, Striano P, Beccaria F. Changes in panayiotopoulos syndrome over time. Epilepsia. 2009;50:45–48.
   PubMed Web of Science ®Google Scholar
• Verrotti A, Sebastiani M, Giordano L, et al. Panayiotopoulos syndrome with convulsive status epilepticus at the onset: a long-term study. Seizure. 2014;23:728–731.
   PubMed Web of Science ®Google Scholar
• Chiappini E, Venturini E, Principi N, et al. Update of the 2009 Italian Pediatric Society Guidelines about management of fever in children. Clin Ther. 2012;34:1648–1653.
   PubMed Web of Science ®Google Scholar
• Schnaiderman D, Lahat E, Sheefer T, et al. Antipyretic effectiveness of acetaminophen in febrile seizures: ongoing prophylaxis versus sporadic usage. Eur J Pediatr. 1993;152:747–749.
   PubMed Web of Science ®Google Scholar
• Van Esch A, Van Steensel-Moll HA, Steyerberg EW, et al. Antipyretic efficacy of ibuprofen and acetaminophen in children with febrile seizures. Arch Pediatr Adolesc Med. 1995;149:632–637.
   PubMed Web of Science ®Google Scholar
• McIntyre J, Robertson S, Norris E, et al. Safety and efficacy of buccal midazolam versus rectal diazepam for emergency treatment of seizures in children: a randomised controlled trial. Lancet. 2005;366:205–210.
   Google Scholar
• Ashrafi MR, Khosroshahi N, Karimi P, et al. Efficacy and usability of buccal midazolam in controlling acute prolonged convulsive seizures in children. Eur J Paediatr Neurol. 2010;14:434–438.
   Google Scholar
• Holsti M, Dudley N, Schnk J, et al. Intranasal midazolam vs rectal diazepam for the home treatment of acute seizures in pediatric patients with epilepsy. Arch Pediatr Adolesc Med.  2010;164:747–753.
   Google Scholar
• Fişgin T, Gurer Y, Teziç T, et al. Effects of intranasal midazolam and rectal diazepam on acute convulsions in children: Prospective randomized study. J Child Neurol. 2002;17:123–126.
   Google Scholar
• Malu CK, Kahamba DM, Walker TD, et al. Efficacy of sublingual lorazepam versus intrarectal diazepam for prolonged convulsions in sub-saharan Africa. J Child Neurol. 2013;29:895–902.
   Google Scholar
• Ahmad S, Ellis JC, Kamwendo H, et al. Efficacy and safety of intranasal lorazepam versus intramuscular paraldehyde for protracted convulsions in children: an open randomised trial. Lancet. 2006;367:1591–1597.
   Google Scholar
• Lissauer S, Kenny J, Jefferis O, et al. Buccal, intranasal or intravenous lorazepam for the treatment of acute convulsions in children in Malawi: An open randomized trial. African Journal of Emergency Medicine. 2015;5:120–126. Available from: http://www.afjem.org/article/S2211-419X(15)00031-2/abstract
   Google Scholar
• Welch RD, Nicholas K, Durkalski-Mauldin VL, et al. Intramuscular midazolam versus intravenous lorazepam for the prehospital treatment of status epilepticus in the pediatric population. Epilepsia. 2015;56:254–262.
   Google Scholar
• Momen AA, Azizi Malamiri R, Nikkhlah A, et al. Efficacy and safety of intramuscular midazolam versus rectal diazepam in controlling status epilepticus in children. Eur J Paediatr Neurol. 2015;19:149–154.
   Google Scholar
• Abou-Khalilc B, Wheless J, Rogin J, et al.  A double-blind, randomized, placebo-controlled trial of a diazepam auto-injector administered by caregivers to patients with epilepsy who require intermittent intervention for acute repetitive seizures. Epilepsia. 2013;54:1968–1976.
   Google Scholar
• Verrotti A, Milioni M, Zaccara G. Safety and efficacy of diazepam autoinjector for the management of epilepsy. Expert Rev Neurother. 2015;15:127–133.
   Google Scholar
• Chamberlain JM, Okada P, Holsti M, et al. Lorazepam vs diazepam for pediatric statusepilepticus: A randomized clinical trial. JAMA. 2014;311:1652–1660.
   Google Scholar
• Wu W, Zhang L, Xue R. Lorazepam or diazepam for convulsive status epilepticus: a metaanalysis. J Clin Neurosci. 2016;29:133–138.
   Google Scholar
• Arya R, Gulati S, Kabra M, et al. Intranasal versus intravenous lorazepam for control of acute seizures in children: a randomized open-label study. Epilepsia. 2011;52:788–793.
   Google Scholar
• Brophy GM, Bell R, Claassen J, et al. Guidelines for the evaluation and management of status epilepticus. Neurocrit Care. 2012;17:3–23.
   Google Scholar
• Babl FE, Sheriff N, Borland M, et al. Emergency management of paediatric status epilepticus in Australia and New Zealand: Practice patterns in the context of clinical practice guidelines. J. Paediatr Child Health. 2009;45:541–546.
   Google Scholar
• Yasiry Z, Shorvon SD. The relative effectiveness of five antiepileptic drugs in treatment of benzodiazepine-resistant convulsive status epilepticus: A meta-analysis of published studies. Seizure. 2014;23:167–174.
   Google Scholar
• Glauser T, Shinnar S, Gloss D, et al. Evidence-based guideline: Treatment of convulsive status epilepticus in children and adults: Report of the Guideline Committee of the American Epilepsy Society. Epilepsy Curr. 2016;16:48–61.
   Google Scholar
• Trinka E. The use of valproate and new antiepileptic drugs in status epilepticus. Epilepsia. 2007;48(Suppl 8):49–51.
   Google Scholar
• Malamiri RA, Ghaempanah M, Khosroshahi N, et al. Efficacy and safety of intravenous sodium valproate versus phenobarbital in controlling convulsive status epilepticus and acute prolonged convulsive seizures in children: a randomised trial. Eur J Paediatr Neurol. 2012;16:536–541.
   PubMed Web of Science ®Google Scholar
• Agarwal P, Kumar N, Chandra R, et al. Randomized study of intravenous valproate and phenytoin in status epilepticus. Seizure. 2007;16:527–532.
   Google Scholar
• McTague A, Kneen R, Kumar R, et al. Intravenous levetiracetam in acute repetitive seizures and status epilepticus in children: Experience from a children’s hospital. Seizure. 2012;21:529–534.
   Google Scholar
• Brigo F, Bragazzi N, Nardone R, et al. Direct and indirect comparison meta-analysis of levetiracetam versus phenytoin or valproate for convulsive status epilepticus. Epilepsy Behav. 2016;64:110–115.
   Google Scholar
• https://clinicaltrials.gov/ct2/show/study/NCT01960075
   Google Scholar
• Arkilo D, Gustafson M, Ritter FJ. Clinical experience of intravenous lacosamide in infants and young children. Eur J Paediatr Neurol. 2016;20:212–217.
   Google Scholar
• Grosso S, Zamponi N, Bartocci A, et al. Lacosamide in children with refractory status epilepticus. A multicenter Italian experience. Eur J Paediatr Neurol. 2014;18:604–608.
   Google Scholar
• Rossetti AO, Logroscino G, Bromfield EB. Refractory status epilepticus: effect of treatment aggressiveness on prognosis. Arch Neurol. 2005;62:1698–1702.
   Google Scholar
• Novy J, Logroscino G, Rossetti AO. Refractory status epilepticus: a prospective observational study. Epilepsia. 2010;51:251–256.
   Google Scholar
• Abend NS, Dlugos DJ. Treatment of refractory status epilepticus: Literature review and a proposed protocol. Pediatr Neurol. 2008;38:377–390.
   Google Scholar
• Reznik ME, Berger K, Claassen J. Comparison of intravenous anesthetic agents for the treatment of refractory status epilepticus. J Clin Med. 2016;19:5.
   Google Scholar
• Chidambaran V, Costandi A, D'Mello A. Propofol: a review of its role in pediatric anesthesia and sedation. CNS Drugs. 2015;29:543–563.
   Google Scholar
• Tasker RC, Goodkin HP, Sánchez Fernández I, et al. Refractory status epilepticus in children: Intention to treat with continuous infusions of midazolam and pentobarbital. Pediatr Crit Care Med. 2016;17:968–975.
   Google Scholar
• Gaspard N, Foreman B, Judd LM, et al. Intravenous ketamine for the treatment of refractory status epilepticus: a retrospective multicenter study. Epilepsia. 2013;54:1498–1503.
   Google Scholar
• Mewasingh LD, Sékhara T, Aeby A, et al. Oral ketamine in paediatric non-convulsive status epilepticus. Seizure. 2003;12:483–489.
   Google Scholar
• Yildiz B, Citak A, Uçsel R, et al. Lidocaine treatment in pediatric convulsive status epilepticus. Pediatr Int. 2008;50:35–39.
   Google Scholar
• Wilkes R, Tasker RC. Pediatric intensive care treatment of uncontrolled status epilepticus. Crit Care Clin. 2013;29:239–257.
   Google Scholar
• Akyildiz BN, Kumandaş S. Treatment of pediatric refractory status epilepticus with topiramate. Childs Nerv Syst. 2011;27:1425–1430.
   PubMed Web of Science ®Google Scholar
• Blumkin L, Lerman-Sagie T, Houri T, et al. Pediatric refractory partial status epilepticus responsive to topiramate. J Child Neurol. 2005;20:239–241.
   PubMed Web of Science ®Google Scholar
• Bleck TP. Refractory status epilepticus in 2001. Arch Neurol. 2002;59:188–189.
   Google Scholar
• Vezzani A. Epilepsy and inflammation in the brain: overview and pathophysiology. Epilepsy Curr. 2014;14:3–7.
   Google Scholar
• Shorvon S, Ferlisi M. The treatment of super-refractory status epilepticus: a critical review of available therapies and a clinical treatment protocol. Brain. 2011;134:2802–2818.
   Google Scholar
• Broomall E, Natale JE, Grimason M, et al. Pediatric super-refractory status epilepticus treated with allopregnanolone. Ann Neurol. 2014;76:911–915.
   Google Scholar
• Schmitt FC, Buchheim K, Meierkord H, et al. Anticonvulsant properties of hypothermia in experimental status epilepticus. Neurobiol Dis. 2006;23:689–696.
   Google Scholar
• Corry JJ, Dhar R, Murphy T, et al. Hypothermia for refractory status epilepticus. Neurocrit Care. 2008;9:189–197.
   Google Scholar
• Guilliams K, Rosen M, Buttram S, et al. Hypothermia for pediatric refractory status epilepticus. Epilepsia. 2013;54:1586–1594.
   Google Scholar
• Kossoff EH, Nabbout R. Use of dietary therapy for status epilepticus. J Child Neurol. 2013;28:1049–1051.
   Google Scholar
• Nabbout R, Mazzuca M, Hubert P, et al. Efficacy of ketogenic diet in severe refractory status epilepticus initiating fever induced refractory epileptic encephalopathy in shool age children (FIRES). Epilepsia. 2010;51:2033–2037.
   Google Scholar
• Logroscino G, Hesdorffer DC, Cascino G, et al. Mortality after a first episode of status epilepticus in the United States and Europe. Epilepsia. 2005;46:46–48.
   PubMed Web of Science ®Google Scholar
• Lowenstein DH. Status epilepticus: an overview of the clinical problem. Epilepsia. 1999;40(suppl. 1):S3–S8, discussion S21–S22.
   Google Scholar
• Aguglia U, Sueri C, Gasparini S, et al. Relevance of clinical context in the diagnostic-therapeutic approach to status epilepticus. Epilepsia. 2016;57:1527–1529.
   PubMed Web of Science ®Google Scholar